6.
Luchsinger J, Younes N, Manly J, Barzilay J, Valencia W, Larkin M
. Association of Glycemia, Lipids, and Blood Pressure With Cognitive Performance in People With Type 2 Diabetes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2021; 44(10):2286-2292.
PMC: 8740937.
DOI: 10.2337/dc20-2858.
View
7.
De Miguel C, Rudemiller N, Abais J, Mattson D
. Inflammation and hypertension: new understandings and potential therapeutic targets. Curr Hypertens Rep. 2014; 17(1):507.
PMC: 4418473.
DOI: 10.1007/s11906-014-0507-z.
View
8.
Goldman M
. Lung dysfunction in diabetes. Diabetes Care. 2003; 26(6):1915-8.
DOI: 10.2337/diacare.26.6.1915.
View
9.
Hsueh W, Wyne K
. Renin-Angiotensin-aldosterone system in diabetes and hypertension. J Clin Hypertens (Greenwich). 2011; 13(4):224-37.
PMC: 8673350.
DOI: 10.1111/j.1751-7176.2011.00449.x.
View
10.
Emdin C, Khera A, Natarajan P, Klarin D, Zekavat S, Hsiao A
. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease. JAMA. 2017; 317(6):626-634.
PMC: 5571980.
DOI: 10.1001/jama.2016.21042.
View
11.
Carter A, Sanderson E, Hammerton G, Richmond R, Davey Smith G, Heron J
. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021; 36(5):465-478.
PMC: 8159796.
DOI: 10.1007/s10654-021-00757-1.
View
12.
Dale C, Fatemifar G, Palmer T, White J, Prieto-Merino D, Zabaneh D
. Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis. Circulation. 2017; 135(24):2373-2388.
PMC: 5515354.
DOI: 10.1161/CIRCULATIONAHA.116.026560.
View
13.
Cheung B, Li C
. Diabetes and hypertension: is there a common metabolic pathway?. Curr Atheroscler Rep. 2012; 14(2):160-6.
PMC: 3314178.
DOI: 10.1007/s11883-012-0227-2.
View
14.
Bozorgmanesh M, Hadaegh F, Zabetian A, Azizi F
. Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran Lipid and Glucose Study. Diabet Med. 2011; 28(11):1330-6.
DOI: 10.1111/j.1464-5491.2011.03343.x.
View
15.
Xu M, Huang Y, Xie L, Peng K, Ding L, Lin L
. Diabetes and Risk of Arterial Stiffness: A Mendelian Randomization Analysis. Diabetes. 2016; 65(6):1731-40.
DOI: 10.2337/db15-1533.
View
16.
Davey Smith G, Ebrahim S
. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003; 32(1):1-22.
DOI: 10.1093/ije/dyg070.
View
17.
Petrie J, Guzik T, Touyz R
. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018; 34(5):575-584.
PMC: 5953551.
DOI: 10.1016/j.cjca.2017.12.005.
View
18.
Engstrom G, Wollmer P, Valind S, Hedblad B, Janzon L
. Blood pressure increase between 55 and 68 years of age is inversely related to lung function: longitudinal results from the cohort study 'Men born in 1914'. J Hypertens. 2001; 19(7):1203-8.
DOI: 10.1097/00004872-200107000-00004.
View
19.
Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O
. Localization of fat depots and cardiovascular risk. Lipids Health Dis. 2018; 17(1):218.
PMC: 6138918.
DOI: 10.1186/s12944-018-0856-8.
View
20.
Walker V, Vujkovic M, Carter A, Davies N, Udler M, Levin M
. Separating the direct effects of traits on atherosclerotic cardiovascular disease from those mediated by type 2 diabetes. Diabetologia. 2022; 65(5):790-799.
PMC: 8960614.
DOI: 10.1007/s00125-022-05653-1.
View